Baseline ACL Injury Risk Screening and Normative Data
1 other identifier
observational
5,000
1 country
1
Brief Summary
This is a prospective, observational cohort study aimed at establishing a database of normative biomechanics for healthy athletes and surveying these athletes for 12 months following baseline testing for the occurrence of new musculoskeletal injuries, with a particular emphasis on ACL injuries.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2022
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 19, 2022
CompletedFirst Submitted
Initial submission to the registry
October 8, 2024
CompletedFirst Posted
Study publicly available on registry
October 10, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2032
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2033
April 17, 2026
April 1, 2026
10 years
October 8, 2024
April 14, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of injury
The primary outcome measure will assess the incidence of ACL injuries among participants. This metric will be determined by responses to a follow-up survey administered at 6 and 12 months post-injury risk screen. Participants will be asked whether they sustained an injury that prevented them from participating in their sport or activity for 10 or more consecutive days. The measure will capture any new ACL injuries occurring within the specified follow-up period.
12 months from baseline
Eligibility Criteria
Community sampling.
You may qualify if:
- Healthy athletes participating in formal, organized, competitive sports between the ages of 10 and 65 years old
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sanford Healthlead
Study Sites (1)
Sanford Health
Fargo, North Dakota, 58103, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Colin Bond, PhD, MBA
Sanford Health
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 8, 2024
First Posted
October 10, 2024
Study Start
July 19, 2022
Primary Completion (Estimated)
July 1, 2032
Study Completion (Estimated)
July 1, 2033
Last Updated
April 17, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share